SCHEMBL7803097

SCHEMBL7803097

CCCn1cnc2c1c(=O)n(CC(C)=O)c(=O)n2C

nearest known ligand 0.75

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TRPA1 O75762 3/20 0.75
PDE4A P27815 9/20 0.74
LMNA P02545 1/20 0.74
ESR1 P03372 1/20 0.74
CYP1A2 P05177 1/20 0.74
MAPT P10636 1/20 0.74
NFKB1 P19838 1/20 0.74
ACHE P22303 1/20 0.74
BLM P54132 1/20 0.74
PMP22 Q01453 1/20 0.74
ADORA2B P29275 5/20 0.71
PDE4B Q07343 8/20 0.69
PDE4C Q08493 8/20 0.69
PDE4D Q08499 8/20 0.69
ADORA2A P29274 4/20 0.63
MAPK1 P28482 1/20 0.56
RXFP1 Q9HBX9 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7793161 0.88 PDE4A (0.84) TRPA1PDE4ALMNAESR1CYP1A2
SCHEMBL9682866 0.86 RXFP1 (0.77) TRPA1PDE4ALMNAESR1CYP1A2
SCHEMBL7798793 0.86 PDE4A (0.93) TRPA1PDE4ALMNAESR1CYP1A2
SCHEMBL30885730 0.86 PDE4A (0.78) PDE4ALMNAESR1CYP1A2MAPT
SCHEMBL17619850 0.86 TRPA1 (1.00) TRPA1PDE4ALMNAESR1CYP1A2
Propentofylline SCHEMBL74602 0.85 PDE4A (1.00) TRPA1PDE4ALMNAESR1CYP1A2
SCHEMBL25778327 0.85 PDE4A (0.71) PDE4ALMNAESR1CYP1A2MAPT
SCHEMBL31411994 0.85 PDE4A (0.71) PDE4ALMNAESR1CYP1A2MAPT
SCHEMBL7800905 0.84 PDE4A (0.98) TRPA1PDE4ALMNAESR1CYP1A2
SCHEMBL25246280 0.84 PDE4A (0.71) TRPA1PDE4ALMNAESR1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0811623-B1 Xanthine derivatives with end-aminated alkynol side chains HOECHST AG (DE) 2001-04-04 EP disclosed
US-5965555-A TREATMENT AND/OR PROPHYLAXIS OF CEREBROVASCULAR DISORDERS CHARACTERIZED BY DAMAGE CAUSED BY ISCHEMIA AND SUBSEQUENT NECROTIC DESTRUCTION OF NERVE CELLS(NEURONS) HOECHST AKTIENGESELLSCHAFT (DE) 1999-10-12 US disclosed
EP-0811623-A1 Xanthine derivatives with end-aminated alkynol side chains HOECHST AKTIENGESELLSCHAFT (DE) 1997-12-10 EP disclosed